129118-11-2 Usage
Description
N-Methoxy-N-methylpentanamide, also known as N-Methyl-N-methoxypentylamine, is a chemical compound with the molecular formula C7H15NO2. It is a clear, colorless liquid with a faint amine odor.
Uses
Used in Pharmaceutical Industry:
N-Methoxy-N-methylpentanamide is used as a precursor in the synthesis of pharmaceuticals and other organic compounds for its ability to facilitate the creation of various medicinal agents.
Used in Chemical Synthesis:
N-Methoxy-N-methylpentanamide is used as a solvent in chemical synthesis processes, providing a medium for reactions to occur and potentially enhancing the efficiency of certain chemical reactions.
Used in Coatings, Adhesives, Sealants, and Elastomers Industry:
N-Methoxy-N-methylpentanamide has potential applications in the field of coatings, adhesives, sealants, and elastomers, where it may contribute to the properties of these materials, such as adhesion, flexibility, or durability.
Safety Note:
It is important to handle N-Methoxy-N-methylpentanamide with caution as it can cause irritation to the skin, eyes, and respiratory system. Proper safety measures should be taken during its use and handling.
Check Digit Verification of cas no
The CAS Registry Mumber 129118-11-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,9,1,1 and 8 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 129118-11:
(8*1)+(7*2)+(6*9)+(5*1)+(4*1)+(3*8)+(2*1)+(1*1)=112
112 % 10 = 2
So 129118-11-2 is a valid CAS Registry Number.
129118-11-2Relevant articles and documents
CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE
-
Paragraph 000458; 000459; 000590; 000591, (2018/01/17)
Described herein are compounds, methods of making such compounds, pharmaceutical compositions and medicaments containing such compounds, and methods of using such compounds to treat or prevent diseases or disorders associated with the enzyme ceramide galactosyltransferase (CGT), such as, for example, lysosomal storage diseases. Examples of lysosomal storage diseases include, for example, Krabbe disease and Metachromatic Leukodystrophy.
Highly efficient and environmentally benign preparation of Weinreb amides in the biphasic system 2-MeTHF/water
Pace, Vittorio,Castoldi, Laura,Alcantara, Andres R.,Holzer, Wolfgang
, p. 10158 - 10162 (2013/09/02)
A straightforward chromatography-free preparation of Weinreb amides starting from acid halides has been achieved in the biphasic medium 2-MeTHF/water. Analytically pure compounds were isolated in excellent yields simply after removal of 2-MeTHF, which abs
Efficient Conversions of Carboxylic Acids into O-Alkyl, N-Alkyl and O,N-Dialkylhydroxamic Acids
Katritzky, Alan R.,Kirichenko, Nataliya,Rogovoy, Boris V.
, p. 2777 - 2780 (2007/10/03)
Carboxylic acids were conveniently converted into unsubstituted, N-alkyl-, O-alkyl-, and O,N-dialkylhydroxamic acids via acylbenzotriazole intermediates. The ready availability of the reagents, mild conditions, and easy handling of the intermediates are advantageous.
